Predicting risk of ovarian malignancy improved screening and early detection feasibility study

Not Applicable

• Conditions: Prevention of ovarian cancer; Cancer; Malignant neoplasm of ovary

• Registration Number: ISRCTN54246466
• Lead Sponsor: Queen Mary University of London

Brief Summary

2019 Abstract results in http://dx.doi.org/10.1136/ijgc-2019-ESGO.65 qualitative results presented at the European Society of Gynaecological Oncology (ESGO) conference (added 20/01/2021)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-06-20
• Last Update Posted: 27 September 2021
• Study Completion: 2024-05-01

Recruitment & Eligibility

• Status: Ongoing
• Sex: Female
• Target Recruitment: 140

Inclusion Criteria

Women aged =18 years

Exclusion Criteria

1. Past history of tubal cancer/ovarian cancer/primary peritoneal cancer
2. Personal history of genetic testing for ovarian cancer predisposing genes

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> Acceptability and uptake of the study:<br> 1. Acceptability measured by responses to the decision aid questions and overall score (prior to consent)<br> 2. Uptake measured as number of individuals who express interest in participating in the study (by post/email/telephone) who sign consent form 1<br>